TMDX logo

TransMedics (TMDX)

Profile

Full Name

TransMedics Group, Inc.

Ticker Symbol

TMDX

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

May 2, 2019

Indexes

Not included

Website

http://www.transmedics.com

Employees

728

Key Details

Price

$88.24(+3.35%)

Market cap

$2.97B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$441.54M(+82.74% YoY)

Annual EPS

$1.07(+238.96% YoY)

PE ratio

87.37

Next earnings date

Apr 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$88.24
TMDX price is $88.24

30-Day Relative Volume

0.92
TMDX 30-day relative volume is 0.92

Price Performance

Price Most recent change

+3.35%
TMDX price was up +3.35% on Apr 17, 2025

Price YTD change

+41.52%
TMDX price is up +41.52% since January 1st

Price 1-year change

+0.43%
TMDX price is up +0.43% year-on-year

Price 3-year change

+275.81%
TMDX price is up +275.81% over the past 3 years

Price Range

Price All-time high

$177.37
TMDX price is currently -50.25% below its historical high of $177.37

Price 3-year low

$20.36
TMDX price is currently +333.40% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$2.97B
TMDX market capitalization is $2.97 billion

Market cap 3-year change

+352.17%
TMDX market capitalization is up +352.17% over the past 3 years

Market cap All-time high

$5.90B
TMDX market capitalization is currently -49.63% below its historical high of $5.90 billion

Market cap sector rank

86.58%
TMDX market capitalization is higher than 86.58% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2.47%
TMDX shares outstanding is up +2.47% year-on-year

Shares Outstanding 3-Year Change

+20.32%
TMDX shares outstanding is up +20.32% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.22
TMDX beta is 1.22

200-day SMA

$103.96
TMDX price is currently -15.12% below its 200-day simple moving average

50-day SMA

$72.09
TMDX price is currently +22.40% above its 50-day simple moving average

RSI

70.61
TMDX 14-day relative strength index is 70.61

Volume

0.92
TMDX 30-day relative volume is 0.92

ATR

$5.14
TMDX average true range is $5.14

10-day Historical Volatility

75.74%
TMDX 10-day historical volatility is 75.74%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$441.54M
TMDX annual revenue is $441.54 million

Revenue Analysts estimate

$540.54M
TMDX annual revenue is currently -18.31% lower than the consensus analysts' forecast

Revenue 1-year change

+82.74%
TMDX annual revenue is up +82.74% year-on-year

Revenue Sector rank

72.65%
TMDX annual revenue is higher than 72.65% of companies in Healthcare sector

EPS

EPS

$1.07
TMDX annual earnings per share is $1.07

EPS Analysts estimate

$1.50
TMDX annual earnings per share is currently -28.89% lower than the consensus analysts' forecast

EPS 1-year change

+238.96%
TMDX annual earnings per share is up +238.96% year-on-year

EPS Sector rank

89.73%
TMDX annual earnings per share is higher than 89.73% of companies in Healthcare sector

Profit

Gross profit

$262.08M
TMDX annual gross profit is $262.08 million

Gross margin

59.36%
TMDX annual gross profit margin is 59.36%

Operating profit

$37.50M
TMDX annual operating income is $37.50 million

Operating margin

8.49%
TMDX annual operating profit margin is 8.49%

Net income

$35.46M
TMDX annual net profit is $35.46 million

Net margin

8.03%
TMDX annual net profit margin is 8.03%

Expenses

Total expenses

$404.04M
TMDX annual total expenses is $404.04 million

Operating expenses

$224.59M
TMDX annual total operating expenses is $224.59 million

Cost of goods sold

$179.46M
TMDX annual cost of goods sold is $179.46 million

Selling, general & administrative expenses

$168.62M
TMDX annual SGA is $168.62 million

Depreciation and amortization

$19.76M
TMDX annual depreciation & amortization is $19.76 million

Interest expense

$14.41M
TMDX annual interest expense is $14.41 million

Income tax

$316.00K
TMDX annual income tax is $316.00 thousand

EBIT & EBITDA

EBIT

$50.19M
TMDX annual earnings before interest & taxes is $50.19 million

EBITDA

$69.95M
TMDX annual EBITDA is $69.95 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$804.08M
TMDX annual total assets is $804.08 million

Non current assets

$306.86M
TMDX annual long term assets is $306.86 million

Current assets

$497.22M
TMDX annual total current assets is $497.22 million

Cash and cash equivalents

$336.65M
TMDX annual cash & cash equivalents is $336.65 million

Accounts receivable

$97.72M
TMDX annual accounts receivable is $97.72 million

Inventory

$46.55M
TMDX annual inventory is $46.55 million

Liabilities

Total liabilities

$575.47M
TMDX annual total liabilities is $575.47 million

Long term liabilities

$515.56M
TMDX annual total long term liabilities is $515.56 million

Current liabilities

$59.91M
TMDX annual total current liabilities is $59.91 million

Accounts payable

$10.29M
TMDX annual accounts payable is $10.29 million

Debt

Total debt

$518.29M
TMDX annual total debt is $518.29 million

Total debt 1-year change

+0.45%
TMDX annual total debt is up +0.45% year-on-year

Long term debt

$515.56M
TMDX annual long term debt is $515.56 million

Short term debt

$2.73M
TMDX annual short term debt is $2.73 million

Equity & Capital

Shareholders equity

$228.60M
TMDX annual stockholders equity is $228.60 million

Book value

$228.60M
TMDX annual book value is $228.60 million

Retained earnings

-$468.24M
TMDX annual retained earnings is -$468.24 million

Working capital

$437.30M
TMDX annual working capital is $437.30 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$48.80M
TMDX annual cash flow from operations is $48.80 million

Cash from operations 1-year change

+474.6%
TMDX annual cash flow from operations is up +474.6% year-on-year

Cash from investing

-$129.30M
TMDX annual cash flow from investing activities is -$129.30 million

Cash from investing 1-year change

+33.33%
TMDX annual cash flow from investing activities is up +33.33% year-on-year

Cash from financing

$22.87M
TMDX annual cash flow from financing activities is $22.87 million

Cash from financing 1-year change

-94.29%
TMDX annual cash flow from financing activities is down -94.29% year-on-year

CAPEX

CAPEX

$129.74M
TMDX annual capital expenditures is $129.74 million

CAPEX 1-year change

-27.54%
TMDX annual capital expenditures is down -27.54% year-on-year

Free Cash Flow

Free cash flow

-$80.94M
TMDX annual free cash flow is -$80.94 million

Free cash flow 1-year change

+57.86%
TMDX annual free cash flow is up +57.86% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

59.36%
TMDX annual gross profit margin is 59.36%

Operating margin

8.49%
TMDX annual operating profit margin is 8.49%

Net margin

8.03%
TMDX annual net profit margin is 8.03%

ROA & ROE

ROA

4.70%
TMDX annual return on assets is 4.70%

ROE

19.39%
TMDX annual return on equity is 19.39%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

87.37
TMDX price to earnings ratio is 87.37

PE ratio Sector rank

88.73%
TMDX price to earnings ratio is higher than 88.73% of companies in Healthcare sector

PB Ratio

PB ratio

12.99
TMDX price to book ratio is 12.99

PB ratio Sector rank

94.89%
TMDX price to book ratio is higher than 94.89% of companies in Healthcare sector

PS Ratio

PS ratio

6.73
TMDX price to sales ratio is 6.73

PS ratio Sector rank

72.91%
TMDX price to sales ratio is higher than 72.91% of companies in Healthcare sector

Enterprise value

Enterprise value

$3.15B
TMDX enterprise value is $3.15 billion

Enterprise value Sector rank

85.54%
TMDX enterprise value is higher than 85.54% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

45.06
TMDX EV/EBITDA is 45.06

EV/EBITDA Sector rank

96.69%
TMDX EV/EBITDA is higher than 96.69% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

8.30
TMDX annual current ratio is 8.30

Quick ratio

7.52
TMDX annual quick ratio is 7.52

Leverage

Debt to equity

2.23
TMDX annual debt to equity ratio is 2.23

Interest coverage ratio

3.48
TMDX annual interest coverage ratio is 3.48

Risk & Stability

Piotroski F-Score

6
TMDX piotroski f-score is 6

Altman Z-Score

3.69
TMDX altman z-score is 3.69

Analyst ratings

Recent major analysts updates

Mar 26, 25 Needham
Hold
Mar 11, 25 Canaccord Genuity
Buy
Feb 5, 25 Needham
Hold
Dec 17, 24 JP Morgan
Neutral
Dec 11, 24 Piper Sandler
Overweight
Dec 11, 24 Needham
Hold
Dec 11, 24 Baird
Outperform
Dec 3, 24 Oppenheimer
Outperform
Dec 3, 24 Needham
Hold
Nov 22, 24 Needham
Hold

Institutional Ownership

Similar stocks

SHC logo
Sotera Health (SHC)
MRUS logo
Merus NV (MRUS)
AKRO logo
Akero Therapeutics (AKRO)
AMED logo
Amedisys (AMED)
OSCR logo
Oscar Health (OSCR)
SRRK logo
Scholar Rock Holding (SRRK)
PRCT logo
PROCEPT BioRobotics (PRCT)
BTSG logo
BrightSpring Health Services (BTSG)
HAE logo
Haemonetics (HAE)
  • What is the ticker symbol for TransMedics?
  • Does TransMedics pay dividends?
  • What sector is TransMedics in?
  • What industry is TransMedics in?
  • What country is TransMedics based in?
  • When did TransMedics go public?
  • Is TransMedics in the S&P 500?
  • Is TransMedics in the NASDAQ 100?
  • Is TransMedics in the Dow Jones?
  • When was TransMedics's last earnings report?
  • When does TransMedics report earnings?
  • Should I buy TransMedics stock now?

What is the ticker symbol for TransMedics?

The ticker symbol for TransMedics is NASDAQ:TMDX

Does TransMedics pay dividends?

No, TransMedics does not pay dividends

What sector is TransMedics in?

TransMedics is in the Healthcare sector

What industry is TransMedics in?

TransMedics is in the Medical Devices industry

What country is TransMedics based in?

TransMedics is headquartered in United States

When did TransMedics go public?

TransMedics's initial public offering (IPO) was on May 2, 2019

Is TransMedics in the S&P 500?

No, TransMedics is not included in the S&P 500 index

Is TransMedics in the NASDAQ 100?

No, TransMedics is not included in the NASDAQ 100 index

Is TransMedics in the Dow Jones?

No, TransMedics is not included in the Dow Jones index

When was TransMedics's last earnings report?

TransMedics's most recent earnings report was on Feb 27, 2025

When does TransMedics report earnings?

The next expected earnings date for TransMedics is Apr 30, 2025

Should I buy TransMedics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page